T-CELL-MEDIATED IMMUNOPATHOLOGY VERSUS DIRECT CYTOLYSIS BY VIRUS - IMPLICATIONS FOR HIV AND AIDS

被引:205
作者
ZINKERNAGEL, RM
HENGARTNER, H
机构
来源
IMMUNOLOGY TODAY | 1994年 / 15卷 / 06期
关键词
D O I
10.1016/0167-5699(94)90005-1
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
It has been much debated as to whether CD4(+) T-cell depletion and the pathogenesis of AIDs is the result of direct cytolytic effects of human immunodeficiency virus (HIV), T-cell apoptosis by nonspecific activation, dysregulation of cytokine production, or autoimmunity. In this context, Rolf Zinkernagel and Hans Hengartner discuss data from model infections with non-cytopathic viruses. They suggest that HIV may cause immunosuppression, not by direct cytolytic effects, but rather by a conventional virus-specific cytotoxic T-cell-mediated immunopathology.
引用
收藏
页码:262 / 268
页数:7
相关论文
共 67 条
[1]  
ANDREAE M, 1988, EUR J CELL BIOL, V47, P181
[2]   HIV-INFECTION - WHY THE LONG LATENT PERIOD [J].
BANGHAM, CRM ;
MCMICHAEL, AJ .
NATURE, 1990, 348 (6300) :388-388
[3]   ENHANCEMENT OF DISEASE BY NEUTRALIZING ANTIVIRAL ANTIBODIES IN THE ABSENCE OF PRIMED ANTIVIRAL CYTOTOXIC T-CELLS [J].
BATTEGAY, M ;
KYBURZ, D ;
HENGARTNER, H ;
ZINKERNAGEL, RM .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1993, 23 (12) :3236-3241
[4]  
BIBERFELD P, 1987, ACTA PATH MICRO IM A, V95, P47
[5]   LONGITUDINAL-STUDY OF 94 SYMPTOMATIC INFANTS WITH PERINATALLY ACQUIRED HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - EVIDENCE FOR A BIMODAL EXPRESSION OF CLINICAL AND BIOLOGICAL SYMPTOMS [J].
BLANCHE, S ;
TARDIEU, M ;
DULIEGE, AM ;
ROUZIOUX, C ;
LEDEIST, F ;
FUKUNAGA, K ;
CANIGLIA, M ;
JACOMET, C ;
MESSIAH, A ;
GRISCELLI, C .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1990, 144 (11) :1210-1215
[6]   NATURALLY-OCCURRING MISSENSE MUTATION IN THE POLYMERASE GENE TERMINATING HEPATITIS-B VIRUS-REPLICATION [J].
BLUM, HE ;
GALUN, E ;
LIANG, TJ ;
VONWEIZSACKER, F ;
WANDS, JR .
JOURNAL OF VIROLOGY, 1991, 65 (04) :1836-1842
[7]   INFECTION OF LYMPHOCYTES BY A VIRUS THAT ABORTS CYTOTOXIC LYMPHOCYTE-T ACTIVITY AND ESTABLISHES PERSISTENT INFECTION [J].
BORROW, P ;
TISHON, A ;
OLDSTONE, MBA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 174 (01) :203-212
[8]  
Buchmeier M J, 1980, Adv Immunol, V30, P275, DOI 10.1016/S0065-2776(08)60197-2
[9]   QUANTITATIVE-ANALYSIS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1)-SPECIFIC CYTOTOXIC LYMPHOCYTE-T (CTL) RESPONSE AT DIFFERENT STAGES OF HIV-1 INFECTION - DIFFERENTIAL CTL RESPONSES TO HIV-1 AND EPSTEIN-BARR-VIRUS IN LATE DISEASE [J].
CARMICHAEL, A ;
JIN, X ;
SISSONS, P ;
BORYSIEWICZ, L .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (02) :249-256
[10]  
CHALIFOUX LV, 1987, AM J PATHOL, V128, P104